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Balmrao KOlleI'll, .H,f) , Adrian Cassacilla, M,D" 
lallles Bmnnan, ~1Ka" SllIllI::lI!Juro /tUltslIki, .\1,0" 
alld Thol/las E, Star:!. J1.D" Ph,D. 
:\ccurding to the :\ational Cancer Institute's statistics, U.600 new 
cases uf malignant tumors of the liver and biliary p,lssages were expected 
to (lCCllr ill 19K6 in the l' nitecl States, ~ The optim,d treatment for malignant 
livt'r tumors is partial or subtotal resection of the livcr. These dav's resection 
can be dont' with a low ll1ortalitv. 12 The resectability rates reported vary 
from ;) per cent to :30 per cent in different series," Conceptuall" total 
hepatectomy f()llowed by orthotopic liver transplantation would be the onl, 
possible surgical method of cure if the tUlllor was too extensive to be 
resected withollt a total hepatectomy while ,till being confined solt·lv to 
the liH'!'. The same ,sit\lation applies if a conventional resection \\'as to be 
preclllded 1)\ coexisting cirrho~isI 
In the initial development of liver transpbntatiull as a clinical proce-
ell! re, extensive hepatic tumors were thought to \w an ideal indication, 
Thus, the second recipient of an orthotopic liver transplantation \vas ,U1 
incli\'idllal \Iith a hepatoma in it cirrhotic liver, The first relatively long-
term sllnivo1' of' a liver transplant was an individual with a hepatoma \\'ho 
died 1:3 months after transplantation clue to tUll1O!' recurrence. 17 As the 
experience with liver transplantation incrcased and as the t()lIowup of 
patients transplanted t()r malignant tumors grew, it became quite clear that 
the results of transplantation tor hepatic malignancy were not as good as 
initially expected, C" With the lise ofcyclosporine I,C\,\), livcr transplantation 
results improved dramatically, 21 Figure 1 shows the Cllltllilative sUrl'il'al 
Clll'\e f(l]' l):30 consl'cllti\'e\v' transplanted patients and a second cur\'c t(lI" 
the 70 patients with lllali,e:nallt tUlllors who werc transplanted llsing CL-\ 
as thl' major il1lll\unosllpprcssive agent. I' Even thOlldl the cat'lv posto[)el'-
F\'IlIII 11." Ikl'Clrlllll'1I1 of SlIrl.!:tTI', l'lIiler,'it\ H"alth <:"IItl'r of l'ithlH.rl.!:h, l'lIiVl'r,il\ "I' 
l'ithhll1'l(h, <IIHI tilt' \'t'l,'raIL' -I.dlllillistratioll \I"dll',,1 (:,'ult-r. I'ittshttrt;h, P"ll""" ,lIIia 
'ittl'!,'"l"d III l\",<"m'il Cranh frolll tilt' \'d"LlltS-I.c\nlillhtr.tli()1l ""d l'royd Cr,,"t "" ,\\1 
2()'Jfil fronl th,> \:,lti()Il,tI Ill'tililtl" ,,1' 1I",tlth, B"tl"",L, \Lln I.,,"d 
(;/J'/ r",'ul'·"''''',,-11 ('Iillin "f \"1'11. ,\IIII''''I'(/-\O\. 17, \:0, l, \I..rdl :'1.'",> 177 
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Figure I. Cllillulatiw survival of all 830 ft'cipit'nts with all diagnoses t'OInpart'd with 70 
recipiellt> wIth malIgnant tUl1l0rs transpl,mkd during C)A t'ra. 
ati\"(:' death rates were similar for the two groups, the recipients transplanted 
for hepatic malignancy have heen plagued by dinicalk evident recurrences 
of their tumors. which ha\'(> frequently resulted in the death of the recipient. 
As a result of this experience, a serious question remains: Do the results 
achiewd justify continued efforts at treating malignant diseases of the liver 
with transplantation? 
In the combined Denw'r-Pittshurgh experiellce, during the precyclo-
sporine era, 13.5 per cent of recipients had hepatic malignancy as the 
indication for liv'er transplantation compared to a figure of 5.6 per cent 
during the cyclosporine era. In contrast to this American experience, 
malignant tumors of the liver have consistently been a larger fraction of the 
total European experience. In the recent report of the European liver 
transplant registry. indiYiduals with malignant tumors comprised 29.14 pef 
cent of the total experience,' In the individual Sf Ties of the Hannover 
group, tumor has been the principal indic,ltion in 33.S per cent of the 
cases,l(I Despite the greater experience with tumor as an indication for 
transplantation, the overall European results ha\'e heen equally as disap-
pointing as tlw American experience with this particular indieation. 
There are, howe\'er. some rays of hope. For example, patients with 
incidentall\' discoHTed hepatomas in tht~ir hepatectomy specimen hav'ing 
heen removed f()r some other indication have uniformly done \\ell. ~1orED­
O\('r. paticlJts with certain histological type:, of hepatie maligllancies haw 
had hetler sur\'i\als than have others. 
III this article we will present data on 70 patients (Table U (adult;, and 
children: \\'ith either primarY Illalil.(nant or mctastatic tllmor~K who wert' 
trealPd by orthotopic: li\t'r transplantation during the cyclosporine era at 
the l ni\'eIsit\ of Colorado Health Sciencl's Cenkr il 980), at the l' nivnsit~ 
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Table 1. Histology of .\[aligllllnt Ucer TUlIlors Treated Iii} Orthotopic Licer 
Transplantatioll During the Cyc/osporine Ern 
Primary 
lIt'patoma 
Ht'patocelluiar 
Fibrolamel1ar 
Silt' duct cancer 
Epithelioid hemangioendoth"liollia 
\\i,cf'llaneous ,cmgiU'<lrCOIlla l. 
cholangiocarcinoma I, unclassified ;21 
\letastatic 
"eUrDenciocrine tumors 
Leiomyosarc'oma 
.\denocarcinoma of unknown origin 
TOTAL 
P~ 
9 
54 
r ., 
ll' 
6 
~ 
-; 
-. ;:) 
iO 
179 
'One patient was transplanted l()r metastatic carcmoul tumors .. \ bile duct cancer was 
deteded in the hepatedoill~D specimen. 
of Pittsburgh \1981-July 1987), or the l'niversity of Pittsburgh's affiliate 
program at Baylor l' niversity ~fedical Center in Dallas (April 19UKD~-g uly 
191j71. 
EVALl' A TION AND SELECTION OF CANDIDATES 
Clearly, not all patients with primary hepatic malignancies unresectable 
bv conventional means are candidates for total hepatectomy and orthotopic 
liver transplantation. In general the presence of distant met,lstases is an 
absolute contraindication for liver transplantation except for a very fe\v 
select histological types (fibrolamellar variant of hepatocellular carcinoma 
and epithelioid hemangioendotheliomill of tumor; thus it is necessary to 
evaluate each of these potential candidates for the presence of extrahepatic 
disease. 
Overt intraabdominal spread is usually ruled out by reviewing previous 
operative records and a CT scan of the abdomen. The presence of pulmonary 
metastases is evalu,lted by routine chest roentgenograms and a Full chest 
CT scan. Intracranial tumor spread is evaluated by either a CT scan or a 
nuclear magnetic resonance image (\[RIl of the head. The possibility of 
skeletal metastases is investigated with a bone searl. Frequently degenera-
tive disease of the spine and old traumatic lesions, particularly of the ribs, 
can cause confusion. A bone biopsy should be obtained in such instances 
from the suspicious site. Using the above methods, combined with a 
thorou~h ahdominal exploration, the presence of metastatic disease can 
almost always be detected either prior to or at the time of transplantation. 
However, micrometastases are still frequently not detectable with current 
methods and continue to be responsible for posttransplant recurrences and 
recipient death. 
Quite often a final decision regardin~ transplantatioll is not possible 
until the patient has had an abdominal exploration once a suitable organ 
becomes availahle. At this point the intraabdominal extent of the disease 
and presencl' of ~lf1EFther primarv tumor could he assessed. 
I80 eyBte~EF KO,\FHt 1-:1 AI.. 
lccasiEFnall~ individuals who arc transplanted tilf all indicatioll other 
thall lflali~ll<l1lEIy are f(l1llld to haH' a coillci(lelltal mali~nanEDyD in their 
hepatectomy sp~>eigleDnK Typically these patients han' hel'n ('yal;lall'd as is 
an\' otlwr indi\'idual with endstagc \in'f disease when the unr('(."ognized 
mI~lignancy has not played a roll' in the pfetransplant decision-making 
process. 
In patients with sderosing cholangitis. an attempt should be made to 
obtain bfushings of the hiliary tree (percutaneous transhepatic Of endos(."opic 
retrograde route) for cytologic evaluation. because hik duct cancer is 
/i·p<}ut'lltly found in such caws. \loreoH'r. clinically it is sometimes quite 
difficult to distinguish between primary sclerosing cholangitis and hill' duct 
carcinoma. particularly in patients without a history of inflammatory howel 
disease and a relatively short history of cholestatic liver disease. Despit{' 
tlwse precautions. patients with primary sclerosing cholangitis stand a 10 
per cent chancc of having a coincidental hile duct carcinoma in their 
Iwpaketon1\' specimen. I. 
SURGICAL TECH;\iIQUE 
(see also "Surgical Technique of Orthotopic Liver Transplantation) 
\\'hen Jiver transplantation i~ performed for a malignant liver tumor, 
ccrtain modifications of the usual transplant procedure are utilized. 19 In all 
such cases. another patient is used as a "hack-up" eandidate so that if the 
pretrallsplant abdominal exploration and dissection reveal extrahepatic 
extension. the transplant call be discontinued and the donor liver is 
transplanted into the "back-up" candidate rather than being wasted. 
Although the preoperative screening proeedures used to detect extra-
hepatic tllmor spread are relatiH'ly accurate. a careful assessment of the 
ahdomen of all such recipients for the spread of the tumor should be made 
at each such potential transplant procedure to determine that the tumor i~ 
confined onh to the liver. The hilar structures are carefulh assessed f(Jr 
tumor thron;bi in vessels and hilar lymph nodes. Any susp'icious looking 
ti~sue ,omentum, lymph nodes. and peritoneal nodules) is examined In 
frozen section. All ~f the hilar. paraduodenaL and suprapancreatic Ivmph 
nodes are removed with the hepatectomy specimen. The hepatectomy 
specimen should include a wide excision of the gastrohepatic ligament. th;, 
hepatoduodpnal ligament. and a skeletonization of the vascular struEDturED~ 
away from the hilum An\' structure attached to the liwf (diaphragm and 
omentum) in thc area of tht' tumor is also excised. The eommon hill' duct 
should be transected oistalh behino the duodenum. and a Roux-en-Y 
choledochojt'julJostomy i~ tl;(' prekrred method of subsequent biliar~ 
draillage of the allograft. 
It is important to be sure thaI allY tUlIlor in the liver is primar\, alld 
not a metastatic tUlllor arising in SO IlH.' other abdominal organ. In very ran' 
C~bes a metastatic tumor coexisting WIth a primary tumor \vill be dete('\t'd 
either during the evaluation procedures or during the "transplant" explo-
ratio]). If a dccisioll is mad(' to proc('ed with the transplant. the priman 
tumor should he H'st'ded prior to tIl!' hepatt'ctol1l\ ill order to avoid all\ 
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'pread of tUlllor cells to the allo!!;raft while the tumor is being excised \see 
.1150 section on mctdstatic tumors. page 1~91K . 
HEPATOCELLULAR CARCI:\,O\IA (:\,O:\FIBROLA\IELLAR) 
This is the most common l()fJll of primary liver malignancy. It is more 
common in the c~yr East. where a high percentage of such patients are 
positi\'e t()r hepatitis B \'irus, A. Ltrge percentage of these tumors are 
llllresectable bv comentional means when they are first diagnosed. :\s a 
result. total hepatectomy followed 1)\ orthotopic liver transplantation is the 
only possible surgical !;xm of therapy, .\ very high rate of posttransphnt 
recurrences plagucs these patients and adversely affccts their long-term 
survival. 
Thirty-four patients with hepatocellular carcinoma have been trans-
planted by liS in the cyclosporillt' era. These cases can be divided into two 
~roups based on the indication f(x transplantation, Grollp 1 comprises l-! 
patients in whom the inoicatioll tor transplant was endstage liver disease 
secondary to any of a Illultitude of noncancerous etiologies. Each of these 
had an i;lcidEDnt~l hepatocellular carcinoma. The indications for transplan-
tation in these cases are itemized in Table 2. 
Their ages ranged from :3 to .'5:3 years with the average being 26 years. 
Only --! were males .. \11 survived the perioperative period. Seven had two 
or more malignant lesions in their hepatectomy specimen. The tUlllors 
varied in size from 0,5 cm to 1.0 em in diameter. None of these 14 had 
any lymph node involvement. 
Onlv 1 of these 1-1 cast's has had a recurrence. This single patient had 
recurrellce in the lumbar spine 17 months following transplantation ano 
died 6 months later (OT No. :3-1-1), initiallv he was thought to have 
disseminated small cell cancer of the lung and was reported as such in a 
previous p1lblication ii'om Ollr center. At autopsy he had involvement of 
liver allograft. lungs. lumbosacral spine. and ribs. Review of the autopsy 
material hv three independent pathology groups has confirmed the disease 
as heing a recllrrence of the hepatocellular carcinoma. He had !l1ultifocal. 
wpll-ditkrt'lltiatcd hepatocelluLir lD~yrCilllma (Iar1-!:t'st tumor nodule :3.,5 cm 
in diameter) in the original hcpatcdOlm specimen. Still unclear is what 
bctors contributed to the unbridled nature of his tumor cOlllpared to that 
of the otlwl's in this group, 
The n'mainilll!; 1:3 patients in this group arc alivf' and free of disease 
IS2 
with h)l\o\\'lIps ranging from .3 to 7:3 months; 6 of the 1.1 haH' SIlrYi\l,d 
bcyond 3 y{Dar~K The longest .,uniYillg paticilt had a poorly difkrentiakd 
hepato('ellular carcinoma (2 .. 5 cnl ill diamcter'! that arose iii a setting of 
cirrhosis C<IIlSt'!! by alpha-I-antitrypsin c1pfieicl)(·Y. 
1n Group Z wert' 20 patients who received their liver tramplants with 
hepatocclllliar carcinoma as tlie indicatio]]. Two had had a pn'\'iol1S hepatic 
resection (1 week and 12 \('ars earlipr). E!en'!l were male.,. The a\eragt· 
age of this group was 37.5 ~Dears (range 11-5S \ ears); 9 had other associated 
hepatic diseases (7 post necrotic cirrhosis, 2 tyrosincmia). and 5 had ('yidellC'I' 
of hppatitis B infection. 
Extent of Disease 
All 20 had disease confined solely to tht' liver based upon their 
pretransplant evaluations. At laparotomy, ollly one had disease extending 
on to the diaphragm and abdominal wall. 
Early Deaths 
Fin- of tlH'st' tyyDent~ individuals died within 2 months filllowing their 
transplants as a rf'sult of sOllle earl v postoperative complication. Four of 
these had autopsies, and no residual tumor was found ill any of them. Thus, 
the prctransplant and intraoperativE' evaluation proct'dllres utilized in these 
cases appear to hast' been relatively accurate in detecting t'xtrahepatir 
disease. 
Recurrence 
Fifteen of these twent~ patients survived for periods greater than 2 
months and were evaluated for the presence of disca~{D recurrcnce and 
long-term survival following transplantation. Eight of thesE' 15 dew loped a 
disease recurrence at internlls of 4 to 12 months following their transplant. 
One of these patients died of a myocardial infarction at 14 llJonths \\'ith a 
suspected recurrence in his ribs. Unfortunatel, no autops\' "'as ohtained. 
In cases \\·here recurrences have been seen, the allograft liver was the first 
silc for thc recurrenc(, ill fOUL the lungs were tht' first site of recurrence 
ill three: the skeleton was the site in 1. Vltimateh mal1\ other organs were 
invohed in each such case. 
Late Deaths 
Six of the eight patients with known recurrences and another with 
suspected recurrellce died one to eight months follOWing the first c\'idf'I1cf' 
of their recurrence. All the recurrences seem to occur \\'ithin the first vear 
following transplantation. Six of the total of twenty patienb transpla~ted 
for hepatoma are alin' \\'ith no e\'idence of discase .54. 4c4c. 11, 10. 8, and 6 
months after transplantation Whether the 2 patients survi\ing .54 and 44 
months are "cured" of their tumor remains to lw secn but seems likely. It 
is interesting that each of thesE' 2 patients had a hepatic rcspction prior to 
the transplant. The patient sllr\wing .54 months cle\'elopccl hllminant 
hepatic failure follOWing his original resection and wa" transplanted 1 week 
Iakr. Thc other hacl hacl his hepatic resection 12 \("ar, pre\'iously and 
requirf'd a toLl] hepatectol11\ as his sec()nd procedure heC;ltl',e of cxtellsin' 
recurrence in both Johes. 
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Figure 2. Cumulative sllfviYal of pdtients with hepatocellular carcinoma during Cy.'. era, 
In the rcport from the European Liver Transplant Registry. patients 
with hepatocellular carcinoma (unstratified,1 have had a 30 per cent 2-year 
actuarial survivaLI In the data compiled hy Pichlmayr from 7 European 
centers, :30,.') per cent \48/157) of such patients have survived 1 year or 
more, and 17,1 per cent (27/1.57) have survived for more than 2 years. 
Pichllllavr iillll1d survival to be puorer in patients with associated cirrhosis, 
Lymph node involvement had a severe negative impact on survivaL \I) The 
survival of our patients with hepatocellular carcinoma is shown in Figure 
2, The Group I patients who had an incidental carcinoma did extremely 
well with a single exception (actuarial survival at :2 years, 88 per cent). 
Some of these individuals had relativelv hrge tumors that were poorly 
differentiated histologically. In contrast, the Group II patients who received 
transplants fiJr unresectable tumors did considerably poorer and several 
have died as a result of their recurrent disease (actuarial survival at 19 
months is 22 per centi. Thesc cases clearly document the fact that 
undetectable micrometastases remain even after a total hepatectomy and, 
when present. lead to an early recurrence and eventual death. Immuno-
suppression, a necessity i(JUowing organ transplantation, creates an envi-
ronmcnt conducive to tumor growth, 
The situations with hepatocellular carcinoma and breast cancer appear 
to be similar: Survival in breast cancer has been improved by identifying 
those patients at high risk fi)r harboring micrometastases and administering 
adjuvant therapy (chemo- and hormonal therapy) to them. The application 
of this strategy t<Jllowing liver transplantation has been hampered by a lack 
of any effective chemotherapeutic agents against hepatocellular carcinoma 
and the fear of the added immunosuppression and leucopenia that these 
agents produce. 
1~4 
clBoliA~fbiiAo HEPATOCELlXLAR CARCI:\O\tA 
"Fihrolanwllar" carcinoma of tIlt' linT. a Iwpatocellular carcilloma with 
a hnorahlc prognEFsi~K has heen rccogllil.(,d a, a definite c1inicopathologi('al 
entity sincc 1S:lS0. The unique histolol!;ic featurc, and clinical Iwha\'ior of 
tlw tumor haH' been descrihed ill detail only rcct'ntly hy tIll' repurts of 
Craig and colleagues" and Berman and coworkers. 2 Thi, tumor usually 
()('curs in young adults or adolescents (mean age 23.2 years) with a male to 
female ratio of 1:2. The distinctive histological ftDatur~D of this tumor is ib 
polygonal cells with an abundant eosinophilic cytoplasm and unif(lrmly 
large o\"al and yesicular nuclei. Tht' fihrous stroma of this tumor is composed 
of fibrillar hands of collagen that are arranged in a lamellar manner hetwecn 
groups of tumor cells. The stroma is usually dense at the periphery ami 
fCm11s either a capsule or pseudocapsule. Cirrhosis does not appear to occur 
at an increased rate in individuals with this subgroup of hepatoccllular 
cancer. Typically. these tumors gnl\\' slower, have a higher resectabilih' 
rate. and a longer suryival rate than do other types of Iwpatoct'llular 
carcinoma. r, :2(1 
l\ine patients with this particular \'ariant of hepatocellular carcinoilla 
havc been treated by us using total hepatectomy and orthotopic liwr 
transplantation in the CyA era. The an'rage age at the tinll' of transplan-
tation for this grOllp was 36.1 years and interestingly. sC'wn were males. 
In onl:, one of these nille was the tumor dis('()\'erecl iJ]cielcntalh f()lJowing 
a transplant for postnecrotic cirrhmis (OT 712). A clinical summary of these 
nine patients is gi\('n in Table 3. 
Extent of Tumor 
.'\one of nine individuals with fihrolamellar carcinoma had am known 
distant llH'tastases at the time of the transplant. III two of the l~ilge i,OT 
23L OT 621.: the tumor was found to be infiltrating the diaphragm and 
req1lired excision of a portion of the diaphragm along with tht:' liver. In 3 
(OT 194. OT 338. and OT 970). varying degrees of vascular ill\'<tsion were 
e\'ident upon histologic examination. 
Survival 
Three of these 9 cases han' died of a nontumor-related cause 1. -:. and 
32 months later. All 3 of the;,e cases had had a seriou;, prohlem with theIr 
allograft function alld required retransplantation. ]n the two ca~e~ that were 
autopsied. no evidence of recurrent tumor yyDa~ found. though Olle had 
coincidental adenosquamous carcinoma of the lung. Of the remaining six 
patients. two have died as a direct conseqnence of recurrent disease .32 and 
33 months later. The other four art' alive. hut one has recurrent disease. 
The mean sun'ival fc)r this group has been 30.3 months. 
Recurrence 
Thrcc patients transplanted for fihrolamelbr carcilloma m,miif>st('d 
recurrent disease In one ca~tDK the reCtllTE'llC't' took plac(' sole}, in tht' 
hl!gl!~ Thh patient has had multiple pulmonary re,cdiom alld was f!iy"E~n d 
cours!' of adJunctive dWlliDthtT<lp\·. She is clIrrenth alive and \\'orkill!:' Iidl 
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time, .52 months j()l1()\\'ing her initial recu rrence. The secolld case had a 
recurrencc in the lungs and allograft liver as well as extensiH' ptTitoneal 
implants, In the third. tht' rp(,IIIT('IH:e was confined to the ahdol1len, 
There is no specific mention of this particular variant of hepatocellular 
carcinoma in the rpported European series, ItJ \Vhen these patients arc 
grouped with those ,,-itl! more llsllal types of hepatocellular carcinoma, the 
sun'ival of the entire group appears spuriously better. 
It is of some interest that a limited number of distant metastases may 
not he a contraindication to transplantation for patients with this particutir 
subgroup of hepatocellular carcinoma, Moreover. it appears as if recurrent 
disease should be aggressively treated either by resectional surgery or 
resection combinf'd ",;th chemotherap\'. 
BILE DUCT CARCINOMA 
Bile duct cancers han' been an identifiahle fraction (15,5 per cent) of 
the cases that have been transplanted in our series. On the average, these 
patients have been older than other patients with malignancy as the 
indication for transplantation (43,8 years versus 37.5 years for patients with 
llt'patocellular carcinoma' 
Of the 11 cases in this series, 3 had tumors isolated to their maior bile 
ducts. Ont' of these has actually been transplanted for multiple hepatic 
metastases arising from a small bowel carcinoid. A bile duct cancer was 
found unexpectedly in the hepatectomy specimen. Eight of the cases 
de\'e1oped their hile duct adenocarcinoma in association with scleroSing 
cholangitis, The cOllfse of these patients is shown in Tablc 4. 
Sderosing Cholangitis and Bile Duct Carcinoma 
In six of the eight cases found in association with sclerosing cholangitis, 
the tumor was unsuspected and discovered incidentally within the hepatec-
tomy specimen. In fact in one of them the tumor was missed on the initial 
histological examination of the hepatectomy specimen and was discovered 
onh 6 months later during a re\'iew of the material. One of the remaining 
h\{l patients with a bile duct tumor was suspected to han' a tumor bef<lrt, 
the transplant. but a specific histological diagnosis could not be established 
prior to transplantation, and no gross tumor was found at the time of the 
transplant procedure. In the other patient a gross tumor was e\'ident in the 
hepatic hilum and lymph nodes at the time of the transplant 
Among the 55 patients \\-Ith sclerOSing cholangitis transplanted b~D our 
group, six (11 per cent had adenocarcinoma of the bile ducb. The duration 
of ,clerosillg cholangitis iPSO ill those with and without bile duct cancer!-
W,b similar.!4 Thi, hlldl1Jl: underscores the need felf aggn'ssin' diagnostic 
procedures indlldill\! PTC and ERCP \,ith hrush biopsies of the bile ducts 
111 tht prctranspiallt t:'\JI'liltion of all patients with sckro,inc: cholangitis. 
Earh Deaths 
Twu patient<, transpLmtt'cl jill- bilt' duct cancer dit'd in the earh 
mEFstopt-r~jtgy l' period .. 4 and 22 days' from complications relakd to graft 
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bilure and Sl'psis, One of thes!' two had an autops\, and no residual dis(,<lv 
\vas ddeckd, A third died -t months fi)l1owing the transplant At autopsy, 
('xtcllsiH' rccurn'llCC ill the ahdomillal lymph nod!'" OH]('ntUI1l, and p('J\'ic 
peritoneum was found, This indi,idual was the patient who had gross 
extrahepatic disease cvident at the time ofthe original transplant procedure, 
SCH'l1 out of the nine recipiC'nts who survivt'd tIlt' early postoperative 
period have heen treated with adjuvant upper ahdominal radiation the rap' , 
One of them also received adjll\'ant chemotherapy with 5-fluorouracil. 
Recurrences 
Among these nine patients who survived the initial postoperatiH' 
period, seven de,'e\oped a recurrence at an average of S, 5 months following 
transplantation, Invariahly tumor recurrence has had a disastrous conse-
quence, Six of them died within 5 months of the detection of their 
recurrence, 
The majority of recurrences occurred in the ahdominal cayit\, partic-
ularly withi;) tl;(' hepatic allograft. Olle had distant metastas~s to tbe 
cla\'icle, 
Onh two cases are a!i\'e without evidence of rt'current disease and 
good all~Fgraft f1l1lction 15 months posttransplant. The experience of the 
Camhridge /!:roup has also heen disappointing with regard to this suhgroup 
of cases, '\'one of their eight patients with bile duct carcinoma has suniyed 
more than 1 year. ifi The small Hum bel' of total cases makes it impossihle to 
determine the impact of any specific histopathological feature on subsequent 
sun-i\'al with the exception that the prt'sence of lymph node metastases, 
perineural ilwasion, and residual tumor at a surgical margin have an adn>rse 
afiect lIpon s\lfyival, In our experience four individuals had residual tumor 
at the margins of t}1E'ir resection, four had perineural illyasion, and two had 
lymph node metastases, Consistent with our exptTiencc, Pichlmayr has 
reported a strong influence of the status of lymph nodes upon subsequent 
suni\'al. Specifically those Kith positi\'(' lymph !lodes had dismal suni\al 
rates of 13 per cent at 1 year and 0 per cent at 2 w'ars, In contrast. those 
\yith Iiegatiw Innph nodes had a 100 per cent sur\'ival at 1 year anel an 83 
per cent sm-yj\'aJ at 2 Years, III \\'hether these results will continue in other 
series and with a period of longer fol\owup remains to be determined, 
EPITHELIOID eb~fAlydflb1DyalqebiflMA 
Epithelioid hemangioendothelioma is a relatin'ly recently character-
ized malignant tumor of the liH'r,2) The cell of origin of this tUlllor is an 
endothelial ceIL thm this tumor can occur in any part of the body, not just 
the 1i\('L'" 'onetlwless, ('('casionalh it occurs in the li\t'r as a priman 
tUllwr, It typically gnm, slowly but aggressi\ely with the natural histor\ 
of the disease spauning ') to 10 Yhirs, ,\1 dastases most often occur tu bOllcs 
lymph nodes, and ple'ura 
Factor Y1I1-rebkd antig(>n is delllollstrahk })\ immurlOpnoxidas! 
staining in the lYtoplaSIll oj thest' tUlllors, alld it acts as ,\ specific tumo! 
marker,"' Tlll's(' tumor" are OftCIl multiple and l(lcatt'd in both lob!" 
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precillciIng cmati\!" resection without a total hepatectomv. In such cases 
liver transplantation is the o!lh option <l\ailable. in our series, six transplants 
have LWt'Il per!()f111t'd tt)\, this type of tUIl10L comprising ~Klj per cent of all 
III the llIalignant tumors that were tre'lted bv liver transplantation. The 
patients' ages ranged from 2-+.'" to 37.9 ye~lrp with a mean of :30.8 years. 
Fiftv per cent were males. Two had known distant mda,tases (one to lung 
.. md one to rib: .mel four had extrahepatic intraabdominal disease i . .3 in 
lvmph nodes and 1 in diaphragm) at the time of their transplant. 
Survival and Recurrences 
.\ll six patients with hemangioendothelioma as the indication f(H' 
transplantation survived the procedure and are currently alive without 
evidence uf recurrence with one exception. This patient had a recurrence 
in the upper lobe of a lung and mediastinum :2l months following trans-
plantation. The hvo individuals with distant metastases prior to their 
transplant ha\'e remained stable with no progression of the disease. 
Hepatic allol!;raft function has been good in each case with a followup 
ranging fi'om 10 to -19 months and a mean survival of 22.:3 months to date. 
F our patients have been given adjuvant chemotherapy with adriamvcin 
postoperati\ely. The longest survivor (-19 months) did not receive any 
chemotherapy postoperatively and had tumor involving the diaphragm. 
Because the natural history of this disease is long, it is too early to 
predict the ultimate outcome with transplantation in this particular !1;roup 
of patients. Ishak and colleagues have reported :32 patients with this type 
of liver tumor and t<)Und that these patients survive for long periods without 
any treatment. II \\'hether regional lymph node invoh'ement imposes an 
additional risk in terms of tumor recurrence remains to be determined. 
The role of posttransplant adjuvant chemotherapy in these cases also is yet 
to be defined. The fact remains that in these patients, the presence of a 
limited nUlllber of distant metastases, as is the case with fibrolamellar 
hepatocelluhir carcinoma, is not a contraindication to tLlJ}splantation. 
~fbqApqAqfC TU\10RS OF THE LIYER 
The liver is the organ that is most frequently invohed with metastases 
from tumors arising elsewhere in the body. [n the past, the presence of 
hepatic metastases has been considered to be evidence of iucurability. [n 
recent years, however, there has heen a growing interest in hepatic 
resections as a treatment for certain isolated metastatic lesions, particularly 
those arising from the colon. Long-term survival results tollowing resection 
of such isolated hepatic metastases of colorectal cancer have been reported 
bv several different authors. I. 7 Liver resection is impossible when the 
cntire on!;an is studded with metastases. 
In ·;uch patients, total hepatectomy with orthotopic transplant is the 
only hope for a surgical cure. Currently European centers have the greatest 
experience with this group of patients,l 10 in which colorectal metastatic 
tumors are the largest subgroup. Patient survival has been poor in most 
instances. 
190 
In our series, we treated scven patients with metastatic callcer to the 
liver by total hepatectomy and orthotopic transplantation. This group 
includes three men and four women, whose ages range frmn 35 to 54 Years. 
Five had metastatic neuroendocrine tumors (carcinoid in two, glucagonollla 
in two, and gastrinoma in one). One had metastatic leiomyosarcoma, and 
the last had an adenocarcinoma of unknown origin. In one of the patients 
with metastatic carcinoid, a bile duct carcinoma was discovered incidentallY 
in the hepatectomy specimen. The clinical summaries of these case~ ar~ 
shown in Table 5. 
The metastatic deposits wcre multiple in all seven, and in one case 
the diaphragm was invaded. Of the five patients with neuroendocrine 
metastases, four underwent synchronous total hepatectomy and resection 
of the primary lesions (two small bowel resections and two distal pancrea-
tectomies, including the spleen in one case). 
Survival 
One patient transplanted for metastatic carcinoma died during her 
third transplant. Her first allograft liver failed after 3 months. Within 3 
days of her second transplant, a third was required for primarY graft 
nonfunction, An autopsy showed no demonstrable residual carcinoid tumor. 
The single patient with the coincidental bile duct cancer died 5 months 
posttransplant because of the bile duct carcinoma. 1\0 recurrCllce of the 
carcinoid tumor was evident. A third patient died 21 months after trans-
plantation as the result of recurrent cancer. The other four patients are 
alive 2 to 28 months after transplant (mean followup 14 months). Each has 
good allograft function. One of these four surviving patients has developed 
metastases in the rihs and is receiving chemotherapy. 
Pichlma)'r's compilation of the data available relative to liver transplan-
tation for malignant tumors from seven European centers included a total 
of 43 patients with metastatic liver tumors. Thirty of these had colorectal 
tumors. Twenty-eight per cent of all patients sUlTived one year. and 14 
per cent survived for 2 years or more. j(l 
In the presence of isolated hepatic metastases, liver transplantation 
\,.-ith an intent to cure may be justified in certain special groups of patients: 
These groups include the following: (1) highly selected patients with 
disahling symptoms from hepatic metastases of endocrine tumors (glucagon. 
oma, carcinoid. vipoma, gastrinoma, etc.) that grow slowl\'; (2) patients 
with selected primary intraabdominal tumors with indolent clinical courses; 
and (3) children with metastatic tumors responsive to chemotherapy and 
radiotherapy in \\'hol11 liver replacement might remove all or most of the 
disease. permitting control of smaller foci of residual disease elsewhere by 
other therapeutic modalities (chemotherapy or radiation therapy!. 
PRESE;'I;T STATUS A;'I;D FCTURE PROSPECTS 
All aualvsis of the data presented in thi~ artiC'k pnwiues l'YiUellC'e that 
at present. the ()\·erall results of total ilt'patectol11\· and orthotopiC trans· 
plantation for extensin' hepatiC' neoplasms are not optimal. III these day" 
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of escalating Ilwdical costs and a ~h{FrtagED of donor organs. onc ha~ tu ask 
this qucstio1J: Is it jllstifiahle to pursue efi()rb in treating such cases with 
this ll1odalit\'J -
The use of ('vdosporille and the greater expericllce "'ith the technical 
detaih of the procedure haH' markedly redue'cd tht' IHIIlJiwr of earh 
postoperativ(, deaths 21 This has enahled groups to obscrn' thes(' patients 
for IOllger intervals, in ordcr to actually assess them for tUlllor H:'(,UIT{'nce 
and to df'termiJJ(, the effect of tumor ITCUrJTIl('(' Oil IOJlg-knn suni\aJ. 
This experience has shown us' that among tIlt' .general category of malignant 
hepatiC' tumors. there are certain subgroups of patients whose tumors are 
biologically less virulent, who may be "cured" or han' their disease 
permanentl" controlled with orthotopic liver transplantatioll. 
Progrcss has been hampered by a \'irtual absence of any chemothera-
peutic agents that are effective against bile duet carcinoma and hepatocel-
lular carcinoma. New and hetter chemotherapeutic agents might changt' 
this situation. 
The imillunosuppression transplant paticnts require depresses their 
host immunih against neoplastic cells as well as agaillst the allograft 
resulting in an increased incidence hoth of de non) malignancies''> and a 
decreased ahility to destroy preexistent maligllant ct'lls. I:, qhi~ situation 
promotes the development of metastases that might otherwise ha\(' failt'd 
to become estahlished. 
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